The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to our mission of saving lives and reducing the burden of disease in low-and middle-income countries. We work at the invitation of governments to support them and the private sector to create and sustain high-quality health systems.

CHAI was founded in 2002 in response to the HIV/AIDS epidemic with the goal of dramatically reducing the price of life-saving drugs and increasing access to these medicines in the countries with the highest burden of the disease. Over the following two decades, CHAI has expanded its focus. Today, along with HIV, we work in conjunction with our partners to prevent and treat infectious diseases such as COVID-19, malaria, tuberculosis, and hepatitis. Our work has also expanded into cancer, diabetes, hypertension, and other non-communicable diseases, and we work to accelerate the rollout of lifesaving vaccines, reduce maternal and child mortality, combat chronic malnutrition, and increase access to assistive technology. We are investing in horizontal approaches to strengthen health systems through programs in human resources for health, digital health, and health financing. With each new and innovative program, our strategy is grounded in maximizing sustainable impact at scale, ensuring that governments lead the solutions, that programs are designed to scale nationally, and learnings are shared globally.

At CHAI, our people are our greatest asset, and none of this work would be possible without their talent, time, dedication and passion for our mission and values. We are a highly diverse team of enthusiastic individuals across 40 countries with a broad range of skillsets and life experiences. CHAI is deeply grounded in the countries we work in, with majority of our staff based in program countries.

In India, CHAI works in partnership with its India registered affiliate William J Clinton Foundation (WJCF) under the guidance of the Ministry of Health and Family Welfare (MoHFW) at the Central and States’ levels on an array of high priority initiatives aimed at improving health outcomes. Currently, WJCF supports government partners across projects to expand access to quality care and treatment for HIV/AIDS, Hepatitis, tuberculosis, COVID-19, common cancers, sexual and reproductive health, immunization, and essential medicines.

Learn more about our exciting work: http://www.clintonhealthaccess.org

Program Overview

Type 1 Diabetes Mellitus (T1D) is an auto-immune disease characterized by reduced ability to produce insulin in the body. T1D usually develops in children, adolescents, or young adults, leading to a lifetime dependence on insulin for survival. The condition is associated with a significant strain and poor quality of life, and leading to a high financial burden, for people living with Type 1 Diabetes (PLT1D) and their families. However, with access to timely diagnostic, initiation on treatment and proper management of the condition, people living with T1D can lead healthy and productive lives, while achieving life expectancy comparable to the general population.

There are an estimated 9.4 million PLT1D globally, with India having the second highest share accounting for 8%-10% of the global prevalence. Nearly 18% of children and adolescents with T1D (~0.3 million) live in India, the highest in the world. The incidence of T1D in the 0-19 age group is increasing more than any other age group and is estimated to increase from 8.15 per 100,000 in 2024 to 13.95 per 100,000 by 2040. While the burden of T1D has continued to rise over the years, survival has remained poor. Survival rates for children and adolescents with T1D in India is worse compared to countries with similar socio-economic development. On average, a child diagnosed with T1D at the age of 10 years lives only an additional 29 years of healthy life, contributing to premature mortality and poor quality of life.

There is an urgent need to improve access to screening and diagnosis and to ensure initiation and adherence to treatment for T1D. WJCF’s Type 1 Diabetes program aims at strengthening and improving access to quality T1D care in India, with the overall goal of achieving longer, healthier, and more productive lives for People Living with Type 1 Diabetes. The program aims to address critical barriers to delivery of quality T1D care in India by building awareness, improving access to screening, diagnosis, and treatment services, enabling treatment adherence and self-management, and strengthening governance framework for delivery of T1D care.

Position Summary

WJCF seeks a highly motivated and entrepreneurial individual with outstanding credentials and demonstrated analytical and stakeholder management abilities for the role of Analyst, Type 1 Diabetes. The Analyst will actively support WJCF’s T1D work in India, including analytical support, coordinating programmatic activities, support in monitoring, evaluation and documentation, and extensive stakeholder engagement including external partners.

The ideal candidate should have exceptional interpersonal skills, be able to work independently, be flexible, be comfortable working and coordinating operations across cross-functional teams and have a strong commitment to excellence. The Analyst role is a high impact role for young professionals determined to positively impact public health outcomes and allows for rich stakeholder engagement.

• Support the development and roll-out of guidelines for standardized care for T1D, along with processes and mechanisms to monitor and report progress of roll-out and implementation to stakeholders at national level.
• Co-ordinate and support implementation of programmatic activities, including but not limited to, working with, and engaging with state program teams to plan activities, monitor implementation, and review progress.
• Support designing, implementing, coordinating, and monitoring program activities in states and pilot geographies.
• Anchor research, including literature review and primary research with key stakeholders, synthesize learnings from implementation, and support development of briefs, knowledge papers, and presentations to inform interventions to strengthen T1D care in India and globally.
• Synthesize and document key learnings, and support dissemination to key stakeholders through reports, briefs, presentation decks and other collaterals as needed.
• Identify potential risks and challenges to the implementation and roll-out of activities and plan for / implement suitable mitigation mechanisms to address identified risks.
• Build and maintain trust-based relationships with relevant government stakeholders, development partners, and other stakeholders relevant to the program.
• Support with other responsibilities as requested by the program leadership.